Monthly Archives: February 2016

Featured Stories

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Harness Problem Prompts Recall of More than 56,000 Child Safety Seats

The baby and child product company Evenflo has recalled more than 56,000 child safety seats because in one of its modes, the child can loosen the internal harness, and will not be properly secured in the seat, increasing the risk … Continue reading

Posted in Defective Products, Product Recalls |

Blood Pressure Drugs May be Harmful for Type 2 Diabetes Patients

For some patients with type 2 diabetes, intense blood-pressure-lowering medication may do more harm than good, according to a new study published in the BMJ. Antihypertensive medication may raise the risk of cardiovascular death for some people with type 2 … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Testimony Continues in DePuy Pinnacle Bellwether Trial

A bellwether trial happening in the Northern District of Texas is focusing on injuries allegedly caused by the DePuy Orthopaedics Pinnacle metal-on-metal hip implant. The outcome of this trial could affect many other pending Pinnacle lawsuits. The plaintiffs allege the … Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants |

Increased Dementia Risk Linked to Heartburn Drugs Linked to Use of Proton Pump Inhibitors for Heartburn

New research suggests that the use of certain drugs for gastric reflux or peptic ulcers creates an increased risk for dementia in elderly patients. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), Nexium (esomeprazole), and Prilosec (omeprazole), HealthDay reports.

Posted in Defective Products, Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

FDA Urges Hospitals to Stop Using Custom Ultrasonics Duodenoscope Cleaning Machines

The Food and Drug Administration (FDA) has taken new steps in its efforts to deal with a series of superbug infections linked to the duodenoscope, a device used to examine the intestinal tract to diagnose and treat conditions including gallstones. … Continue reading

Posted in Defective Medical Devices, Duodenoscope, Health Concerns |

FDA Expected to Announce Results of Essure Investigation

A number of women are awaiting an announcement from the U.S. Food and Drug Administration (FDA) regarding Essure, a permanent birth control device sold by Bayer. The agency is expected to release the results of its investigation, which was launched … Continue reading

Posted in Legal News |

Legislators and 9/11 First Responders Ring Closing Bell at Stock Exchange to Celebrate Reauthorization of Zadroga Act

On Monday, February 22, 2016, U.S. Representatives Carolyn B. Maloney, Jerrold Nadler, and Dan Donovan joined 9/11 survivors and responders to ring the closing bell at the New York Stock Exchange in honor of the reauthorization of the James Zadroga … Continue reading

Posted in Health Concerns, Toxic Substances |

CDC Warns of Greater Health Risks with Lumber Liquidators Laminate Flooring than Earlier Thought

Some types of laminate flooring made by Lumber Liquidators pose a greater risk of causing cancer or other health problems than previously announced, according to the Centers for Disease Control and Prevention (CDC). The CDC said people who purchased Lumber Liquidators … Continue reading

Posted in Defective Products, Health Concerns, Toxic Substances |

$72 Million Verdict in Talcum-Powder Related Ovarian Cancer Death

A jury in St. Louis has awarded $72 million to the family of an Alabama woman who died from ovarian cancer she said was caused by using Johnson & Johnson’s baby powder and other products containing talcum. This civil suit … Continue reading

Posted in Defective Products, Health Concerns, Legal News |

Jury Returns $72 Million Verdict against Johnson & Johnson in Talcum Powder Related Ovarian Cancer Death

A jury in St. Louis jury returned a $72 million dollar verdict on February 22, 2016 in the case of a woman who died of ovarian cancer. The jury found the cancer was caused by her use of talc-based products … Continue reading

Posted in Health Concerns, Legal News |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.